{"id":563181,"title":"Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T12:56:40.926000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-guidance-industry-preparation-quality-information-radiopharmaceuticals.html","snippet":"Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document Contact: CERB/CBE This document is also available in PDF…","rawSnapshotUrl":"/api/snapshots/raw/563181","browseUrl":"https://replay.healtharchive.ca/job-6/20260216125640/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-guidance-industry-preparation-quality-information-radiopharmaceuticals.html#ha_snapshot=563181","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}